01 1Arevipharma
01 1BUPRENORPHINE HYDROCHLORIDE
01 1Germany
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-16
Pay. Date : 2013-06-27
DMF Number : 24594
Submission : 2011-01-24
Status : Active
Type : II
20
Arevipharma Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BUPRENORPHINE HYDROCHLORIDE, with a corresponding US DMF Number 24594.
Remarkably, this DMF maintains an Active status since its submission on January 24, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 16, 2013, and payment made on June 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
